Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2010-10-05
2011-11-08
Cheu, Jacob (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C436S518000
Reexamination Certificate
active
08053202
ABSTRACT:
The invention provides a method capable of readily discriminating pathologic conditions and judging selection of a therapeutic drug, the degree of the therapeutic effect, discontinuation of medication, etc., wherein stages quantitatively judged by digitizing substances contained in urine, which is different from conventional methods for judging stages of an interstitial pneumonitis which are performed by observation of mucous lesions with endoscopy requiring the skill or by analysis of histological samples collected from the living body. The method measures the value of main metabolites of prostaglandin E (PGE-MUM) concentration in urine and judges stages between the pre-remission phase of interstitial pneumonitis.
REFERENCES:
patent: 2006/0263887 (2006-11-01), Dannenberg
patent: 61-11664 (1986-01-01), None
patent: 2005-30852 (2005-02-01), None
Fujiwara, Mutsunori et al., “Significant Increase in Prostaglandin E-main Urinary Metabolite by Laxative Administration: Comparison with Ulcerative Colitis”, Digestion, 61, pp. 201-206, 2000.
Bippi, H. et al., “Effects of acetylsalicylic acid and paracetamol alone and in combination on prostanoid synthesis in man”, Br. J. clin. Pharmac., 29, pp. 305-310, 1990.
International Search Report mailed Aug. 29, 2006, in PCT/JP2006/307939, filed Apr. 14, 2006.
Extended European Search Report issued Feb. 25, 2011, in Patent Application No. 10190915.8.
European Office Action issued Feb. 15, 2011, in Patent Application No. 06 731 875.8.
Laine J. Murphey, et al., “Quantification of the major urinary metabolite of PGE2by a liquid chromatographic/mass spectrometric assay: determination of cyclooxygenase-specific PGE2synthesis in healthy humans and those with lung cancer”, Analytical Biochemistry, vol. 334, No. 2, XP 4607608, Nov. 15, 2004, pp. 266-275.
D. K. Petkova, et al., “Reduced expression of cyclooxygenase (COX) in idiopathic pulmonary fibrosis and sarcoidosis”, Histopathology, vol. 43, No. 4, XP 2622386, Oct. 1, 2003, pp. 381-386.
Katsutoshi Tsuga, et al., “Evaluation of the colorectal wall in normal subjects and patients with ulcerative colitis using an ultrasonic catheter probe”, Gastrointestinal Endoscopy, vol. 48, No. 5, XP 5689265, Nov. 1, 1998, pp. 477-484.
Fujiwara Mutsunori
Hayashi Yuzo
Okayasu Isao
Cheu Jacob
Fujirebio Inc.
Isao Okayasu
Mutsunori Fujiwara
Oblon, Spivak McClelland, Maier & Neustadt, L.L.P.
LandOfFree
Method for determining the stage of ulcerative colitis or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for determining the stage of ulcerative colitis or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for determining the stage of ulcerative colitis or... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4267833